LRRTM4: A Potential Drug Target and Biomarker (G80059)

Target Name: LRRTM4

NCBI ID: G80059

LRRTM4

LRRTM4: A Potential Drug Target and Biomarker

LRTM4, also known as MGC120633, is a gene that encodes a protein located in the membrane of human cells. The protein produced by this gene has been shown to play a role in the development and progression of various diseases, including cancer. As a result, LRRTM4 has emerged as a promising drug target and biomarker.

The LRRTM4 gene was identified through a variety of genetic studies, including transcriptome analysis and gene expression profiles. These studies revealed that the gene was expressed in a wide range of human tissues and was highly expressed in tissues that are often affected by diseases, such as cancer.

To further investigate the functions of LRRTM4, researchers used a variety of techniques, including cell-based assays and in vitro assays. These studies showed that LRRTM4 was involved in a number of cellular processes, including cell signaling, cell adhesion, and cell survival.

One of the most promising aspects of LRRTM4 is its potential as a drug target. LRRTM4 has been shown to play a role in the development and progression of various diseases, including cancer. By targeting LRRTM4 with drugs, researchers may be able to reduce the risk of disease progression or improve treatment outcomes.

In addition to its potential as a drug target, LRRTM4 has also been shown to be a potential biomarker. The protein produced by this gene has been shown to be expressed in a variety of human tissues and is often used as a marker for disease progression. By detecting LRRTM4 in tissues, researchers may be able to monitor the effectiveness of different treatments and make more informed decisions about disease management.

LRRT

Protein Name: Leucine Rich Repeat Transmembrane Neuronal 4

Functions: May play a role in the development and maintenance of the vertebrate nervous system. Exhibits strong synaptogenic activity, restricted to excitatory presynaptic differentiation (By similarity)

The "LRRTM4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRTM4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets